Intellicheck Announces First Quarter 2022 Financial Results
Intellicheck, Inc. (Nasdaq: IDN) reported a strong first quarter for 2022, with total revenues increasing by 19% to $3,395,000 compared to $2,863,000 in 2021. SaaS revenue surged 21% to $3,353,000. Despite a decrease in the gross profit margin to 90.7% due to rising costs, operating expenses significantly fell to $4,547,000 from $7,281,000. The net loss narrowed to ($1,468,000) or ($0.08) per diluted share, down from ($4,624,000) or ($0.25) per diluted share in the prior year. As of March 31, 2022, cash stood at $11.1 million.
- Total revenue increased 19% to $3,395,000.
- SaaS revenue grew 21% to $3,353,000.
- Net loss improved to ($1,468,000) from ($4,624,000) year-over-year.
- Operating expenses decreased significantly to $4,547,000 from $7,281,000.
- Gross profit margin decreased to 90.7% from 92.3% due to higher cloud service costs.
- Adjusted EBITDA worsened to ($806,000) compared to ($51,000) the previous year.
- Operating expenses increased on a non-GAAP basis by 45% excluding equity compensation.
Total Revenues Grew
“The growth that we experienced during the quarter shows that our clients continue to find new uses for our products and demonstrates that we continue to expand in our core markets and are successfully entering new markets. At the same time, we have continued to advance our strategic priorities to achieve our longer-term growth objectives. The investments we have made in technology and operations are yielding results in serving our market growth and expansion and our clients well,” said
Gross profit as a percentage of revenues was
Operating expenses for the three months ended
Net loss for the three months ended
Adjusted EBITDA (earnings before gains on debt forgiveness, other income, income taxes, depreciation, amortization, equity compensation expense, as well as liability classified awards) was (
As of
The financial results reported today do not consider any adjustments that may be required in connection with the completion of the Company’s review process and should be considered preliminary until
Conference Call Information
The Company will hold an earnings conference call on
A replay of the conference call will be available shortly after completion of the live event. To listen to the replay, please dial 877-660-6853 and use conference identification number 13726737. For callers outside the
|
||||||
BALANCE SHEETS |
||||||
(In thousands except share amounts) |
||||||
ASSETS |
||||||
|
|
|
||||
2022 |
|
2021 |
||||
(Unaudited) |
|
|
||||
CURRENT ASSETS: |
||||||
Cash |
$ |
11,123 |
$ |
13,651 |
||
Accounts receivable, net of allowance of zero and |
2,348 |
2,192 |
||||
Other current assets |
692 |
643 |
||||
Total current assets |
14,163 |
16,486 |
||||
|
|
|||||
PROPERTY AND EQUIPMENT, net |
826 |
737 |
||||
|
8,102 |
8,102 |
||||
INTANGIBLE ASSETS, net |
351 |
378 |
||||
OTHER ASSETS |
8 |
8 |
||||
Total assets |
$ |
23,450 |
$ |
25,711 |
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||
CURRENT LIABILITIES: |
||||||
Accounts payable |
$ |
321 |
$ |
368 |
||
Accrued expenses |
1,768 |
2,870 |
||||
Equity awards liability |
|
|
141 |
|
|
378 |
Liability for shares withheld |
|
|
1,244 |
|
|
1,244 |
Deferred revenue, current portion |
1,032 |
1,266 |
||||
Total current liabilities |
4,506 |
6,126 |
||||
|
|
|||||
OTHER LIABILITIES: |
|
|
||||
Deferred revenue, long-term portion |
6 |
8 |
||||
Total liabilities |
4,512 |
6,134 |
||||
COMMITMENTS AND CONTINGENCIES (Note 10) |
||||||
STOCKHOLDERS’ EQUITY: |
||||||
Common stock - |
19 |
19 |
||||
Additional paid-in capital |
147,284 |
146,455 |
||||
Accumulated deficit |
(128,365) |
(126,897) |
||||
Total stockholders’ equity |
18,938 |
19,577 |
||||
|
|
|||||
Total liabilities and stockholders’ equity |
$ |
23,450 |
$ |
25,711 |
|
|||||||
|
|||||||
STATEMENTS OF OPERATIONS |
|||||||
(In thousands except shares and per share amounts) |
|||||||
(Unaudited) |
|||||||
|
Three months ended |
||||||
|
|
||||||
|
2022 |
|
2021 |
||||
|
|
|
|
||||
REVENUES |
$ |
3,395 |
|
$ |
2,863 |
||
COST OF REVENUES |
|
(316) |
|
|
(221) |
||
Gross profit |
|
3,079 |
|
|
2,642 |
||
|
|
|
|||||
OPERATING EXPENSES |
|
|
|
||||
Selling, general and administrative |
|
2,943 |
|
|
5,945 |
||
Research and development |
|
1,604 |
|
|
1,336 |
||
Total operating expenses |
|
4,547 |
|
|
7,281 |
||
|
|
|
|||||
Loss from operations |
|
(1,468) |
|
|
(4,639) |
||
|
|
|
|||||
OTHER INCOME |
|
|
|
||||
Gain on forgiveness of unsecured promissory note |
|
- |
|
|
10 |
||
Other income |
|
- |
|
|
5 |
||
Total other income |
|
- |
|
|
15 |
||
|
|
|
|||||
Net loss |
$ |
(1,468) |
|
$ |
(4,624) |
||
|
|
|
|||||
PER SHARE INFORMATION |
|
|
|
||||
Loss per common share - |
|
|
|
||||
Basic |
$ |
(0.08) |
|
$ |
(0.25) |
||
Diluted |
$ |
(0.08) |
|
$ |
(0.25) |
||
|
|
|
|||||
Weighted average common shares used in computing per share amounts - |
|
|
|
||||
Basic |
|
18,674,493 |
|
|
18,480,013 |
||
Diluted |
|
18,674,493 |
|
|
18,480,013 |
|
||||||||||||||
|
||||||||||||||
STATEMENTS OF STOCKHOLDERS’ EQUITY |
||||||||||||||
(In thousands except number of shares) |
||||||||||||||
(Unaudited) |
||||||||||||||
|
|
Three months ended |
||||||||||||
|
|
Additional |
|
|
|
Total |
||||||||
Common Stock |
|
Paid-in |
|
Accumulated |
|
Stockholders’ |
||||||||
Shares |
Amount |
|
Capital |
|
Deficit |
|
Equity |
|||||||
|
||||||||||||||
BALANCE, |
18,660,369 |
$ |
19 |
$ |
146,455 |
$ |
(126,897) |
$ |
19,577 |
|||||
|
||||||||||||||
Equity compensation |
- |
|
|
- |
|
|
592 |
|
|
- |
|
|
829 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Issuance of shares for vested restricted stock grants |
|
14,611 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
Net loss |
- |
|
|
- |
|
|
- |
|
|
(1,468) |
|
|
(1,468) |
|
BALANCE, |
18,674,980 |
|
$ |
19 |
|
$ |
147,284 |
|
$ |
(128,365) |
|
$ |
18,938 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three months ended |
||||||||||||
|
|
Additional |
|
|
|
Total |
||||||||
Common Stock |
|
Paid-in |
|
Accumulated |
|
Stockholders’ |
||||||||
Shares |
Amount |
|
Capital |
|
Deficit |
|
Equity |
|||||||
|
||||||||||||||
BALANCE, |
18,410,458 |
$ |
18 |
$ |
141,612 |
$ |
(119,419) |
$ |
22,211 |
|||||
|
||||||||||||||
Equity compensation |
- |
|
|
- |
|
|
981 |
|
|
- |
|
|
981 |
|
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld |
|
181,545 |
|
|
1 |
|
|
1,708 |
|
|
- |
|
|
1,709 |
Issuance of shares for vested restricted stock grants |
|
1,754 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
Net loss |
- |
|
|
- |
|
|
- |
|
|
(4,624) |
|
|
(4,624) |
|
BALANCE, |
18,593,757 |
|
$ |
19 |
|
$ |
144,301 |
|
$ |
(124,043) |
|
$ |
20,277 |
.
|
|||||||
|
|||||||
STATEMENTS OF CASH FLOWS |
|||||||
(In thousands) |
|||||||
(Unaudited) |
|||||||
|
Three months ended |
||||||
|
2022 |
|
2021 |
||||
|
|
|
|
(As Restated) |
|||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|||
Net loss |
|
$ |
(1,468) |
|
$ |
(4,624) |
|
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|
|||
Depreciation and amortization |
|
|
69 |
|
|
43 |
|
Equity compensation |
|
|
592 |
|
|
4,545 |
|
Forgiveness of unsecured promissory note |
|
|
- |
|
|
(10) |
|
Changes in assets and liabilities: |
|
|
|
|
|||
Increase in accounts receivable |
|
|
(156) |
|
|
(148) |
|
Increase in other current assets |
|
|
(49) |
|
|
(215) |
|
Decrease in accounts payable and accrued expenses |
|
|
(1,149) |
|
|
(113) |
|
(Decrease) increase in deferred revenue |
|
|
(236) |
|
|
51 |
|
Net cash used in operating activities |
(2,397) |
(471) |
|||||
|
|||||||
|
|||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|||||||
Purchases of property and equipment |
|
|
(131) |
|
|
(48) |
|
Net cash used in investing activities |
(131) |
(48) |
|||||
|
|
|
|||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|||||
Return of repayment on unsecured promissory note |
|
|
- |
|
|
10 |
|
Net cash provided by financing activities |
- |
|
10 |
||||
|
|
|
|
|
|||
Net decrease in cash |
(2,528) |
(509) |
|||||
|
|
|
|
||||
CASH, beginning of period |
|
13,651 |
|
13,121 |
|||
|
|
|
|
||||
CASH, end of period |
$ |
11,123 |
|
$ |
12,612 |
||
|
|
|
|
||||
Supplemental disclosure of noncash investing and financing activities: |
|
|
|
||||
Reclassification of stock option awards |
$ |
- |
|
$ |
1,411 |
||
|
|
|
Adjusted EBITDA
We use Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by adjusting net loss for certain items such gains on debt forgiveness and other income and certain addbacks such as income taxes, depreciation, amortization, and equity compensation expense. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing our financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as amortization, depreciation, and equity compensation, as well as non-operating charges for interest and income taxes, investors can evaluate our operations and can compare the results on a more consistent basis to the results of other companies. In addition, Adjusted EBITDA is one of the primary measures management uses to monitor and evaluate financial and operating results.
We consider Adjusted EBITDA to be an important indicator of our operational strength and performance of our business and a useful measure of our historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes gains on debt forgiveness, other income, and equity compensation, all of which impact our profitability, as well as depreciation and amortization related to the use of long-term assets which benefit multiple periods. We believe that these limitations are compensated by providing Adjusted EBITDA only with GAAP net loss and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net loss presented in accordance with GAAP. Adjusted EBITDA as defined by us may not be comparable with similarly named measures provided by other entities.
Three Months Ended |
||||||||
|
||||||||
2022 |
|
|
2021 |
|||||
Net loss |
$ |
(1,468) |
$ |
(4,624) |
||||
Reconciling items: |
|
|
|
|
||||
Gain on forgiveness of unsecured promissory note |
|
- |
|
|
(10) |
|||
Other income |
|
- |
|
(5) |
||||
Depreciation and amortization expenses |
|
70 |
|
|
43 |
|||
Equity compensation including liability classified awards |
592 |
|
4,545 |
|||||
Adjusted EBITDA |
$ |
(806) |
$ |
(51) |
||||
About
Safe Harbor Statement
Statements in this news release about Intellicheck’s future expectations, including: the advantages of our products, future demand for Intellicheck’s existing and future products, whether revenue and other financial metrics will improve in future periods, whether
View source version on businesswire.com: https://www.businesswire.com/news/home/20220613005667/en/
Investor Relations:
Media and Public Relations:
Source:
FAQ
What are Intellicheck's Q1 2022 revenue results?
How much did Intellicheck's net loss change in Q1 2022?
What was the status of Intellicheck's operating expenses in Q1 2022?
What is the gross profit margin for Intellicheck in Q1 2022?